Category: ACN Newswire

香港，2025年8月6日 - (亚太商讯 via SeaPRwire.com) - 近日，中国在手术机器人具身智能领域迎来重要技术突破。8月5日，香港中文大学召开新闻发布会，正式宣布由该校多学科团队，携手中国手术机器人企业康诺思腾（Cornerstone Robotics），成功开发出全球首个手术机器人多功能自动化具身智能平台，并在康诺思腾自主研发的Sentire思腾®腔镜手术机器人上，完成了全球首例临床场景下的自主手术验证。相关研究成果以《Surgical Embodied Intelligence for Generalized Task Autonomy in Laparoscopic Robot-assisted Surgery》为题，发表在机器人领域权威期刊《Science Robotics》，该期刊由《Science》杂志旗下出版，最新影响因子为27.5，五年影响因子达32.9，是全球机器人研究领域最具影响力的学术平台之一。这是中国自主研发的腔镜手术机器人在具身智能领域首次完成活体动物实验，并验证多任务自主操作与人机协作能力、算法的通用性与系统的临床可行性，将引领行业朝着更智能、更协同、更普惠的方向加速演进。本研究构建了一种面向手术任务自动化的具身智能新范式--VPPV（Visual Parsing, Perceptual Regressor, Policy Learning, Visual Servoing Controller），通过融合视觉基础大模型的稳健感知能力、强化学习范式的策略泛化能力，以及AI策略与传统控制的分层融合架构，使手术机器人自主操作在稳定性、灵活性与可迭代性方面实现新突破。区别于传统手术自动化方法中，对额外传感器输入或基于人工预定义规则与模型依赖的局限性，该研究成果是全球首创的手术具身智能框架，兼具全景感知、多任务泛化、精细伺服闭环以及人机协同的功能特点，可大幅降低研发与临床应用门槛，为下一代智能手术助手树立新标杆。研究团队基于自主研发的开源仿真平台SurRoL训练出多项具备泛化能力的AI策略，并成功实现"零样本迁移"，该平台集成多模态感知、真实物理建模与多任务操作训练，覆盖手术机器人控制接口、仿真环境与强化学习引擎。为了更接近真实的手术环境，研究团队分别使用离体猪胃组织（保留完整的胃网膜血管）和约30公斤活体猪模型进行了严格的验证实验，两次实验均由康诺思腾自主研发的Sentire思腾®腔镜手术机器人系统完成。在活体动物验证阶段，实验采用了创新的"监督自主性（supervised autonomy）"安全模式，使用Sentire思腾®腔镜手术机器人的高清立体内窥镜系统，无需任何额外传感器，即自主完成了纱布拾取、软组织牵引和血管夹闭等机器人手术辅助核心任务的操作，体现出高度的环境适应性、操控稳定性，以及临床转化的巨大潜力，为"人机共创"的具身智能外科手术协作模式提供现实支撑。康诺思腾联合创始人、首席技术官兼首席运营官王泽睿博士作为本次研究的通讯作者表示："Sentire思腾®腔镜手术机器人作为本次研究的核心系统之一，具备机械架构、电气架构、软件架构、机器人算法、图像信号处理以及高等能量控制等全栈自研的核心技术，这套商业整机手术机器人系统为AI自主方案在动态手术环境中的稳定部署和高精度运行提供了有力的保障。"他进一步指出："康诺思腾始终坚持全栈自研与垂直整合的研发战略，我们的底层技术、软硬件自主开发及系统集成优势，使核心产品系统架构具备卓越的可扩展性，展现出独特的AI就绪及AI友好特性。这不仅支持算法快速适配和部署，也确保机器人系统能够灵活应对不同任务需求与组织场景，真正为智能化手术发展提供了坚实平台。"作为本项研究的技术协作方，康诺思腾团队与香港中文大学研究团队密切配合，成功在自主研发的Sentire思腾®腔镜手术机器人上完成了算法部署和活体验证。这一成果不仅验证了平台的开放架构与高度兼容性，更标志着AI手术辅助技术正加速走出实验室，进入临床转化的前沿。康诺思腾创始人、首席执行官欧国威教授表示："我们始终相信，科研与产业的深度融合是推动高端医疗装备技术突破的关键动力。此次合作不仅验证了具身智能算法在商用手术机器人平台上的实际落地能力，也体现出其在手术自动化领域的巨大应用潜力。康诺思腾将继续携手全球科研与临床伙伴，共同探索复杂任务自动化、人机协作新范式与智能系统监管机制，加速推动具身智能手术机器人走向真实临床。"关于康诺思腾（Cornerstone Robotics）康诺思腾（Cornerstone Robotics）是中国创新型手术机器人的独角兽企业，怀着"引领医疗创新，心系天下健康"的愿景，致力于打造安全高效的手术机器人平台，提升中国乃至全球范围优质医疗资源的可及性，让更多患者受益于高端医疗科技带来的高品质医疗服务。公司已在全球设立四大研发中心，并在中国香港、深圳、北京、上海和美国波士顿、英国朴次茅斯设有分支机构，在粤港澳大湾区建成超万平米的量产工厂。凭借雄厚的技术实力，公司已成功攻克技术难题，搭建起全面底层技术平台，由康诺思腾自主研发的Sentire思腾®腔镜手术机器人已完成多个重要专科的临床试验，并正式获得国家药品监督管理局（NMPA）批准上市，同步在全球范围申请医疗器械认证，服务全球医护，惠及更多病患。如欲了解更多，可浏览：https://www.csrbtx.com/ Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月6日 - (亚太商讯 via SeaPRwire.com) - 品创控股有限公司（「品创控股」或「公司」，连同其附属公司统称为「集团」；股份代号：8066）欣然宣布，集团电子商务业务持续高速增长，取得突破性佳绩。根据集团的全资附属公司山西动创数娱科技集团有限公司（「山西动创」）及赛博幻境（香港）有限公司（「赛博幻境」）各自的未经审核管理账目，截至2025年6月30日止六个月，电子商务业务及人工智能（AI）业务的未经审核总收入及未经审核除税前溢利总额分别达约6,090万港元及5,560万港元，反映集团电子商务业务增长之快速，以及前瞻布局人工智能领域的成功。集团的电子商务业务涵盖泛娱乐数字生态系统会员电子商务平台 ─ 动创电商APP服务平台之运营，以及通过人工智能平台提供语音技术相关服务。集团一直锐意多元化发展业务组合，以把握发展蓬勃的数字经济及人工智能应用新发展商机。为促进业务拓展，集团于2024年收购山西动创，不仅引入具备丰富经验和客户资源雄厚的互联网运营团队，更藉此构筑私域流量运营的竞争优势，为集团进军AI领域及业务升级转型注入强劲动能。私域电商平台的成功运营，不仅驱动集团业绩快速成长，更为集团累积逾10万名忠实会员。这些会员在赛博幻境的人工智能语音技术资料采集与标注业务中，将转化为逾10万的语音素材贡献者，此举将加速推动集团转型升级为人工智能数据服务企业。集团电子商务业务及人工智能业务的卓越表现不仅标志着业务发展的重要里程碑，更为集团把握不断增长的电子商务平台行业及人工智能业务机遇奠定坚实基础。展望未来，集团将继续深耕私域电商平台运营及人工智能业务，全方位拓展电子商务业务，持续强化核心优势，全力推动业务实现高质量发展。同时，集团将继续寻求合适的投资机会，进一步提升集团的增长潜力，致力为股东创造可持续的回报。关于品创控股有限公司品创控股有限公司的使命是妥善运用公司所获得的资本与独特投资机会，为股东提供稳定的优渥收入与获利。品创由三个主要事业部门组成，包括智能卡制造服务、投资服务与资源回收投资，主要业务为生产及销售智能卡、提供定制智能卡应用系统、提供财务及管理咨询服务、废旧金属销售及贸易、以及媒体与娱乐行业之投资。公司的总部位于香港，旗下控股公司与投资则遍布大中华地区。关于山西动创数娱科技集团有限公司山西动创数娱科技集团有限公司（前称"海南动创数娱科技集团有限公司"）从事运营泛娱乐数字生态系统会员电子商务平台，平台主要提供带私域流量的娱乐电子商务，包括提供数字产品及服务。关于赛博幻境（香港）有限公司赛博幻境（香港）有限公司（前称"智能生产管理系统有限公司"）从事提供人工智能语音服务。 Copyright 2025 亚太商讯 via SeaPRwire.com.

JAKARTA, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - Chinese automotive company SERES and electric vehicle brand AITO launched a road tour from Chongqing to Jakarta on Monday (4/8) to test the brand's durability, as well as celebrate 75 years of Indonesia-China diplomatic relations. The "Open the Way with AITO" road tour will pass through several ASEAN countries on its way to Jakarta, covering a route of 5,000 kilometers. Vehicles on the tour are the AITO M5, AITO M7, and AITO M9.Indonesian Chamber of Commerce and Industry China Committee (KIKT) Chairman Garibaldi 'Boy' Thohir, SERES Automobile President Leon He, and Indonesian Ambassador to China and Mongolia Djauhari Oratmangun at Chongqing-Jakarta AITO Road Tour launch in Chongqing, China on Aug 4."The KIKT (Indonesian Chamber of Commerce and Industry Bilateral Committee for China) is here in Chongqing to launch this major event where AITO vehicles will travel a route from Chongqing, China to Indonesia, with a big welcoming event planned on August 25 in Jakarta," said KIKT Chairman Garibaldi "Boy" Thohir to ANTARA after the launch event in Chongqing on Monday.The road tour, titled "Open the Way with AITO," will pass through several ASEAN countries on its way to Jakarta, covering a route of about 5,000 kilometers. The AITO vehicles in the road tour are the AITO M5, AITO M7, and AITO M9."The Chinese government, especially President Xi Jinping, has promoted 'One Belt One Road,' and this is one example of the Silk Road from Chongqing to Indonesia. With this event, we also hope to attract the attention of young people," Boy added.Young people will be represented in the event by celebrities such as Boy William and Gading Marten, as well as Kanjeng Gusti Pangeran Adipati Arya (KGPAA) Mangkunegara X Bhre Cakrahutomo Wira Sudjiwo, commonly known as Gusti Bhre."Because many young people like fun, informal things, I am involving Boy William and Gading Marten to be icons so that young Indonesians can see how far Chinese technology has progressed, and especially the good relationship between the two countries," Boy explained.The Indonesian Ambassador to China and Mongolia, Djauhari Oratmangun, stated that this event was not only related to Indonesia and China but to several ASEAN countries. "This shows that the NEV (new energy vehicle) industry will enter Indonesia and produce in Indonesia for the ASEAN market, and therefore the Indonesian Embassy in Beijing fully supports it," said Ambassador Djauhari. Ambassador Djauhari sees renewable energy vehicles (New Energy Vehicles) as part of the green economy. "We have the materials, especially for producing batteries as the main component of the electric vehicle industry. Therefore, we welcome the presence of the electric vehicle industry in Indonesia, and China has become one of the world's main producers of electric vehicles," Ambassador Djauhari added.In his remarks, Ambassador Djauhari said that young people, innovators, and even tourists are beginning to play a role in Indonesia-China relations. "Events like this spark a curiosity, a spirit of adventure and mutual understanding. As this tour starts from Chongqing, the hope is that it can also bring about a more integrated ASEAN-China region, a more strategic, sustainable, and comprehensive Indonesia-China partnership, and a stronger, more environmentally friendly future," Ambassador Djauhari explained.SERES Automotive President Leon He said that AITO had previously undertaken a similar overland expedition in Europe. "Last year's expedition covered 15,000 km in 38 days to Paris, which proved the toughness of our vehicles. This year, the journey will continue to Indonesia, a strategic market with an economic potential of 150 billion US dollars and a strong commitment to new energy vehicles," said Leon He.Leon He noted that the presence of the SERES factory in Sokonindo, Indonesia since 2017 has been an important stepping stone for expansion in the ASEAN region. The AITO brand itself has not yet entered Indonesia, but SERES Automobile has been present through PT Sokonindo Automobile, which oversees the DFSK brand.The Sokonindo factory has stood since 2017 in the Modern Cikande Industrial Estate, Serang, Banten, covering 20 hectares, with a total investment of USD 150 million and a maximum production capacity of 50,000 units per year for both domestic and international markets. Indonesian Chamber of Commerce and Industry: https://kadin.id/en/ Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 5, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by China’s National Medical Products Administration (NMPA). This approval for production expansion will further boost capacity and increase product supply, enabling a more efficient response to the growing clinical demand in China and across Asia.NEFECON® is the first and only etiological treatment for IgA nephropathy (IgAN) to receive full approval in China, the United States, and Europe, serving as a foundational first-line therapy for patients with IgAN. Since its initial approval in China in November 2023, NEFECON® was subsequently included in the National Reimbursement Drug List (NRDL) in November 2024, and received full approval from the NMPA in May 2025, irrespective of proteinuria levels, benefiting most individuals living with IgAN.NEFECON® specifically modulates the mucosal immune system in the gut to reduce the formation of pathogenic galactose-deficient IgA1 (Gd-IgA1) that trigger IgAN. Results from the Phase 3 clinical study NefIgArd demonstrated that NEFECON® reduces the decline in kidney function by 50%. Results from Phase 3 clinical study NefIgArd of the Chinese population shows that NEFECON® reduces kidney function decline by 66%, and delays disease progression to dialysis or kidney transplantation by 12.8 years.“The expansion of our NEFECON® production capacity will help better meet the growing clinical treatment needs of IgAN patients in China.” Said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “China has one of the highest rates of primary glomerular disease in the world, with more than 5 million patients estimated to be living with IgAN and over 100,000 new cases diagnosed each year. Chinese IgAN patients generally experience faster disease progression and poorer prognosis, highlighting a significant unmet medical need.As the only etiological treatment for IgAN currently recommended by both international and Chinese guidelines, the expansion of NEFECON® production will further accelerate the uptake of etiological treatment, enabling more patients to access standardized treatment earlier to delay disease progression and protect kidney function. We will continue to enhance the accessibility and affordability of NEFECON®, supporting its advancement from ‘changing the treatment landscape’ to ‘redefining the standard of care’.”NEFECON®, as the only in-disease IgAN treatment has been included in the KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (public review draft), making it the only targeted therapy endorsed by both international and Chinese guidelines. NEFECON® has been approved across all Everest Medicines’ territories, including mainland China, Hong Kong SAR, Macau SAR, Taiwan region, China, as well as Singapore and South Korea, and continues to expand its therapeutic impact across Asia.As production capacity continues to grow and supply capabilities improve, NEFECON® is well positioned to benefit a broader patient population by accelerating the uptake of etiological treatment, enabling more patients to access standardized care earlier to delay disease progression and preserve kidney function. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 5, 2025 - (ACN Newswire via SeaPRwire.com) - On August 4, the China Robotics Industry ETF (159551) rose by 2.44%, as investor enthusiasm for the sector continues to surge. Humanoid robotics is transitioning from a phase of “technical breakthroughs” to one of “scenario implementation,” marking the start of a new acceleration cycle. With a series of industry catalysts unfolding, the robotics segment in the Hong Kong market is entering a structural upswing.Among the emerging opportunities, Shoucheng Holdings (0697.HK) stands out as a rare asset platform company with full-chain industrial deployment and real scenario execution capability.1. From Showroom to Deployment: Humanoid Robots Hit the Ground RunningAt the 2025 World Artificial Intelligence Conference (WAIC) held in late July, over 150 humanoid robots were demonstrated performing real-time dynamic tasks across industrial, service, and medical settings — a first in China. Unlike previous static displays, this year’s event showcased robots in real application scenarios such as cleaning, concierge services, and logistics handling, demonstrating the rapid convergence of hardware, algorithms, and computing power.At the same time, major news continues to drive investor sentiment:Unitree Robotics has entered IPO counseling, and the World Robot Conference 2025 is set to launch with over 100 new product debuts.In this context, Shoucheng Holdings stands out as a rare Hong Kong-listed company with both industrial integration capabilities and operational execution power, filling a critical gap in the market.2. From Conference to Application: Shoucheng’s Robot Ecosystem Comes AliveWhile many firms are still stuck in the “capital narrative” stage, Shoucheng Holdings is entering a phase of real industrial depth, evolving from investor to industrial connector and platform enabler.At the upcoming World Robot Conference 2025, Shoucheng is organizing an official sub-forum titled “Robotics Investment and Innovation Forum”, bringing together top-tier founders and venture capitalists to discuss commercialization strategies for humanoid robotics in the so-called “mass production year.” The forum serves as a bridge linking capital, technology, and market demand.In parallel, at the World Humanoid Robot Games, Shoucheng’s subsidiary Beijing Robotics Leasing Co. has provided 78 robots from its portfolio companies — including Booster Robotics, Galaxea-AI, Noetix Robotics, and Galbot — to support training in core competition categories such as football, athletics, and scene-based tasks. Several invested companies are also participating directly, enabling a full cycle of product testing, feedback, and application validation.Shoucheng’s ability to integrate investment, leasing, agency services, and operations has led to the creation of a scalable and repeatable robotics application infrastructure, positioning it as one of the few platform companies in the Hong Kong market with true industrial depth.3. A Rare Valuation Opportunity in Hong Kong’s Robotics MarketWhile many companies in China’s robotics ecosystem are either unlisted or trading at high valuations, Shoucheng Holdings currently trades at just around HK$1.90 and has completed multiple rounds of share buybacks. This signals strong management confidence in the company’s long-term value.In a market that favors “high growth + application-driven” assets, Shoucheng — with its triple focus on robotics, REITs, and medical technology — is emerging as one of the most compelling industrial platforms for investors riding the next robotics wave.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月5日 - (亚太商讯 via SeaPRwire.com) - 8月4日，范式集团与海博思创签署合作协议，双方出资成立合资公司，业务覆盖"AI+储能"领域。这一合作标志着AI在能源存储的深度应用迈出关键一步，将为构建更智能、高效、安全的能源体系注入强大动力。在范式集团创始人戴文渊与海博思创创始人、董事长、首席执行官张剑辉的见证下，范式集团首席财务官刘楠与海博思创董事会秘书、首席财务官高书清代表双方公司签署合作协议，为双方未来的深度合作写下注解。范式集团联合创始人、首席研究科学家陈雨强与海博思创技术总裁杨洸等双方管理团队共同见证了这一重要时刻。AI赋能 范式集团驱动储能智慧升级作为核心技术引擎，范式集团将其在人工智能领域的前沿积累全面注入新公司：依托范式领先的AI Agent+世界模型能力，赋予储能系统前所未有的"智慧大脑"。电力市场AI解决方案能够实时预测电网供需两端的波动，结合储能自身的技术特点，动态优化储能场站的充放策略，提升效率的同时，达到经济收益最大化。与此同时，范式集团在能源行业的智能化应用已然拥有丰富的实践经验，相关技术也已经成功应用于负荷预测、电网优化、虚拟电厂等场景。此次合作将把其在能源领域特有的AI洞察力与海博思创的储能硬件深度融合，实现从"感知"到"决策"再到""执行"的闭环智能管理。坚实底座 海博思创铸就储能卓越基石依托储能系统研发、生产及全生命周期管理领域的技术实践，海博思创将成为合资公司的坚实后盾，提供其在储能系统全链条的顶尖能力：储能作为AI赋能能源革命的核心应用场景，具有重要的战略意义。海博思创以AI技术作为创新驱动力，依托研发、制造、运维、运营、交易等维度的海量数据基础，构建了基于AI算法的储能场景应用平台，实现了储能系统全生命周期的智能化运维管理，有力地推动了企业向综合能源服务商的转型升级。AI+储能 引领智慧能源革命范式集团与海博思创战略携手，绝非简单的技术叠加，而是通过深度协同，解决制约储能大规模发展的核心挑战：海博思创创始人、董事长、首席执行官张剑辉在签约仪式上表示："在全球能源格局重塑的当下，AI技术正成为推动能源变革的关键变量。海博思创与范式集团分别是储能与人工智能领域的领军者。两家公司的理念高度契合，通过此次合作，我们将实现储能技术与AI算法的深度融合，达到1+1>2的协同效应。"提及"AI+储能"，范式集团创始人戴文渊表示，新能源产业空间广阔，但天然波动性与系统复杂性正成为发展瓶颈。破解之道就在于双核驱动：储能构筑能源流转的物理基石，AI打造智能决策的数字中枢--前者稳定"波峰波谷"，后者优化"发-输-配-用"全链条效率。今天，范式集团与海博思创强强联合，将在"AI+储能"领域占有一席之地，创造出高于现有数十倍的产值。范式集团与海博思创的合作，将是储能产业走向数智化的关键一步。当顶尖AI大脑与强健储能躯干完美结合，制约储能大规模发展的种种挑战都被解决，"AI+储能"将释放其前所未有的潜力，共同推动全球能源转型进程。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月5日 - (亚太商讯 via SeaPRwire.com) - 8月4日，机器人产业ETF（159551）上涨2.44%，板块热度持续走高。人形机器人产业正步入从"技术爆点"向"场景兑现"的提速期。随着一系列行业事件密集催化，港股市场机器人板块进入新一轮结构性行情，其中最值得重点关注的标的之一，是已完成全链条布局的资产平台型公司--首程控股（0697.HK）。一、 行业催化不断，人形机器人从展台走向场地7月末举行的2025世界人工智能大会（WAIC）上，首次实现超150台人形机器人动态任务同台展示，覆盖工业、服务、医疗等多个场景，成为AIGC之后AI应用最具想象力的落地方向。与以往"静态展示"不同，本届展会首次呈现"任务级应用"，机器人在清扫、接待、搬运等场景中实现了类人化操控，标志着"硬件+算法+算力"协同模式加速成熟。与此同时，宇树科技开启IPO辅导、智元机器人筹备百台新品发布大会、世界机器人大会即将揭幕等密集消息叠加，正在持续强化板块情绪，并将产业链上的优质标的推向聚光灯下。而在港股市场，具有产业穿透力、已参与核心厂商实战、并掌握"投资+运营"落地能力的代表性公司仍属稀缺，首程控股正好填补这一空白。二、 从大会到应用，首程控股构建机器人产业的"场景通路"在一众仍停留于"资本故事"讲述阶段的公司中，首程控股的机器人战略已走入深水区，其角色正从投资方转向产业链接者与平台推动者。从行业桥梁层面来看，在即将举行的2025世界机器人大会中，首程控股主办了大会官方分论坛"机器人行业创投主题交流会"，聚焦"机器人量产元年"背景下的投资逻辑与场景落地策略。该论坛吸引了数十位头部机器人企业创始人和机构投资人，成为链接技术、资本与产业需求的重要平台。从场景落地层面来看，在同期举办的世界人形机器人运动会上，首程控股亦通过旗下北京机器人租赁公司，为赛事训练阶段提供了包括加速进化、星海图、松延动力在内的78台机器人设备，服务于足球、田径、场景赛等多个核心项目。多家被投企业还将亲自参赛，形成从技术验证到竞技检验的完整闭环。平台协同层面：依托"投资+租赁+代理+运营"的产业架构，首程控股已逐步形成一条覆盖研发、测试、交付、训练、反馈的机器人应用通路，成为港股市场中极少数具备真实产业穿透力的平台型公司。从主办分论坛、到实训设备支持、再到多家被投企业实战参赛，首程控股正在用一整套可复用、可扩展、可沉淀的数据与能力矩阵，持续拓宽机器人产业"从研发到场景"的落地通道。三、港股稀缺估值洼地，产业穿透力打开重估空间在当前国内机器人产业链上行周期中，大量公司仍处于估值高位或尚未上市阶段。而港股市场中，拥有实际运营能力、标的处于低估区间、产业兑现步入加速期的公司极为稀缺。目前首程控股股价仍处于1.9港元附近，已完成连续多轮股份回购，管理层用"真金白银"释放对公司中长期价值的高度认可。在港股资金偏好"高成长+场景逻辑"资产的背景下，具备"机器人+REITs+医疗科技"三重底层资产能力的首程控股，有望成为本轮机器人行情中最具穿透力的产业平台。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亚太商讯 via SeaPRwire.com.

PHILADELPHIA, PA, Aug 6, 2025 - (ACN Newswire via SeaPRwire.com) - TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, today introduced the Certified Global Nurse (CGN), the world's first truly global credential for first-level, general nurses (RNs).TruMerit | Global careers. Care anywhere.The new, merit-based credential is available to any qualified nurse - from any country - to recognize their competencies, regardless of where they choose to live and work. It is awarded upon passage of TruMerit's Nurse Qualifying Exam (NQE), which applicants may take after verification of their nursing education and licensure.Previously known as the CGFNS Qualifying Exam and used by nurses migrating to the United States, the NQE was reinvented with a global focus to support the ongoing evolution of nursing practice worldwide and particularly the emergence of key challenges such as digital health, mental health, and climate change. This was achieved through a collaborative process involving more than 70 nursing experts from 50 countries, with all World Health Organization regions and World Bank country income levels represented. The experts agreed upon a core set of nursing practice standards after analyzing nursing competency frameworks from 37 countries.In addition to its role as a key requirement for the CGN credential, the upgraded exam continues to support other TruMerit programs - such as the VisaScreen® Visa Credentials Assessment Service and the Certification Program® - as a shared global framework for validating the applied knowledge and practice competence of nurses worldwide."The Certified Global Nurse credential offers nurses everywhere a common framework for meeting globally agreed-upon essential nursing practice standards," said Dr. Peter Preziosi, TruMerit's President and CEO. "When nurses carry the credential, their employers and colleagues will know that their applied nursing knowledge and skills are validated against a global benchmark, attesting to their qualifications for delivering quality healthcare."The credential is ultimately intended to provide nurses with greater mobility within the profession, within their native countries, and across geopolitical boundaries throughout their careers."By signifying work-readiness on an international scale, and thereby helping expand the pool of readily identifiable qualified nurses worldwide, global credentialing will become part of the solution to the challenges health systems are facing around the world," said Preziosi."We hope this credential can contribute to a sustained, collaborative effort involving many stakeholders-health ministries, international agencies, health systems, nursing schools, and nursing associations worldwide-to harmonize nursing education and practice and support the future growth of the global nursing workforce," he said.The Nurse Qualifying Exam is a proctored examination that will be offered four times a year at more than 1,000 Kryterion testing centers located around the world, with the first test window scheduled for November 10-14, 2025. Nurses who wish to earn a CGN credential and sit for the NQE in November must apply by September 30 at the TruMerit website, where they will find more information on the credential and how to prepare for the exam.The testing schedule for 2026 will be announced later this year.About TruMeritTruMerit is a worldwide leader in healthcare workforce development. Formerly known as CGFNS International, the organization has a nearly 50-year history supporting the career mobility of nurses and other healthcare workers - and those who license and hire them - by validating their education, skills, and experience as they seek authorization to practice in the United States and other countries. As TruMerit, this mission has been expanded to building workforce capacity that meets the needs of people in a rapidly evolving global health landscape. Through its Global Health Workforce Development Institute, the organization is advancing evidence-based research, thought leadership, and advocacy in support of healthcare workforce development solutions, including globally recognized practice standards and certifications that will enhance career pathways for healthcare workers. www.trumerit.orgContact InformationDavid St. Johndstjohn@trumerit.orgSOURCE: TruMerit Copyright 2025 ACN Newswire via SeaPRwire.com.

佛罗里达州博卡拉顿，2025年8月5日 - (亚太商讯 via SeaPRwire.com) - Atlas Lithium Corporation（纳斯达克股票代码：ATLX）（“Atlas Lithium”或“公司”），一家领先的锂开发公司，很高兴宣布 SGS Canada Inc.（“SGS”）已完成公司百分之百持有的 Neves 锂项目（“项目”）的最终可行性研究（“DFS”），这是一份依据美国《Regulation S-K》第 1300 项（“Regulation S-K 1300”）准则所编制的技术报告。这个硬岩项目非常适合作为低成本的露天采矿作业，因为其锂辉石矿床相对靠近地表。该项目位于巴西米纳斯吉拉斯州，涵盖 Atlas Lithium 拥有的 98 项锂矿权中的 4 项。根据 DFS 的详细资料，Neves 项目预计将带来强劲的财务指标，内部报酬率（“IRR”）为 145%，自开始营运起 11 个月内回本，税后净现值（“NPV”）为 5.39 亿美元。值得注意的是，DFS 预估 Neves 项目的运营生产成本仅为每公吨 489 美元锂精矿，使 Atlas Lithium 成为全球成本最低的生产商之一。这些指标的完整细节已包含于 DFS 中，并作为公司截至 2025 年 6 月 30 日季度财报（Form 10-Q）所附的文件，提交至美国证券交易委员会。Marc-Antoine Laporte 为 DFS 根据 Regulation S-K 1300 所认定的合格人员，来自 SGS——一家在矿产项目测试、检验与认证服务方面享有盛誉的全球领导企业。业界领先的资本效率与低运营成本DFS 报告指出，该项目预计所需的直接资本支出为 5,760 万美元，远低于巴西其他已公告项目的资本成本。值得注意的是，Atlas Lithium 此前已投入约 3,000 万美元，用于购置及运输项目中新制造的致密介质分离（DMS）工厂至巴西。公司已取得两笔非稀释性预付款协议，合计 4,000 万美元锂精矿销售额，并获得其他方的额外资金意向，包括十年期债务融资选项，这些皆可支持项目的资本需求。公司认为，DFS 验证了该项目强劲的经济效益，使其成为全球资本效率最高且硬岩锂矿开发成本最低的项目之一。该项目将采用已验证的 DMS 技术，全面的冶金测试显示预期锂回收率达 61.7%，能生产高品质、低杂质的锂精矿。此相对简单且低风险的 DMS 处理方法，最大限度地降低了技术复杂性与运营风险，同时实现低环境影响。Atlas Lithium 拥有的矿权，详见 DFS 报告，已于 2025 年 5 月 27 日获得巴西矿业暨能源部颁发“Portaria de Lavra”（采矿许可证）资格——这是巴西最高层级的矿权所有权，允许持续进行采矿作业。项目内多个矿床区域沿走向与深度仍有资源扩展空间，预计将延长矿山寿命。此外，项目矿权范围内仍有多处高潜力地质目标，为未来勘探提供诱人机会。本项目位于被称为“锂谷”的 Vale do Jequitinhonha 中已发展完善的 Araçuaí 斑岩区，享有便利的基础设施，包括邻近交通网络、水源与技术熟练的劳动力。该项目符合由巴西整合与区域发展部颁布的东北部发展总署（SUDENE）税收优惠，企业所得税率将从 34% 降至 15.25%，进一步提升获利能力。Atlas Lithium 董事长兼首席执行官 Marc Fogassa 表示：“DFS 显示，我们最初聚焦开发一个低资本需求、短期内可获利的锂生产资产的愿景，可能带来卓越的回报。低资本强度与快速回本期的组合，预计将为股东创造非凡价值，并使 Atlas Lithium 得以受惠于 Neves 项目及我们拥有的其他高潜力锂矿区未来的有机扩展机会。更重要的是，我们在 Vale do Jequitinhonha 地区创造了大量优质就业机会，展现本项目对社会的重大贡献。”资深领导团队推动项目执行在与 SGS 共同完成最终可行性研究（DFS）后，Atlas Lithium 的项目管理主管暨工程副总裁 Eduardo Queiroz 先生负责监督项目执行工作。Queiroz 先生拥有超过二十年的丰富经验，专注于管理复杂且大型的采矿项目。Queiroz 先生表示：“DFS 展现了本项目的技术稳健性，采用经 SGS 这家锂产业顶尖公司验证的成熟致密介质分离（DMS）技术与全面的冶金测试成果。随着我们的加工厂已完全建造且资金到位，且现有 DFS 报告，我们已系统性降低了项目风险。我很荣幸能领导 Atlas Lithium 成为锂生产商之旅的执行阶段。”Salinas 与 Clear：下一个扩展前沿Atlas Lithium 战略性地布局于巴西广泛的区域锂矿勘探组合，特别是通过推进公司百分之百持有的 Salinas 项目与 Clear 项目。Atlas Lithium 的 Salinas 项目距离先前由 Latin Resources 持有的 Colina 锂资产仅 5 英里，该资产是 Pilbara Minerals 于 2024 年以约 3.7 亿美元收购 Latin Resources 的主要原因之一。在 Salinas 项目中，Atlas Lithium 已取得有希望的初步成果，包括发现极靠近地表的富锂辉石斑岩，以及土壤地球化学和 LIDAR 地质测绘的高度正面结果。Atlas Lithium 的 Clear 项目距离 Sigma Lithium 正在运营的锂矿不足 4 英里，展现重大未开发潜力，并同样从土壤地球化学及 LIDAR 地质测绘中获得非常正面的结果。关键矿产多元化布局Atlas Lithium 亦持有 Atlas Critical Minerals Corporation（OTCQB: JUPGF）约 30% 股权，该公司另行从事铀、稀土、钛和石墨的勘探计划。关于 Atlas Lithium CorporationAtlas Lithium Corporation（纳斯达克代码：ATLX）是一家专注于推动 Neves 项目投产的锂开发公司。Neves 项目的最终可行性研究显示卓越的经济效益，内部报酬率达 145%、净现值 5.39 亿美元，且回本期仅 11 个月。Neves 项目已获得运营许可，其致密介质分离工厂亦已购置并运抵巴西。Atlas Lithium 拥有约 539 平方公里的锂矿权，为巴西上市公司中锂矿勘探面积最大的公司。此外，Atlas Lithium 目前持有 Atlas Critical Minerals Corporation（OTCQB: JUPGF）约 30% 股权。安全港声明本新闻稿包含《1933年证券法》第27A条及《1934年证券交易法》第21E条所定义的前瞻性陈述。前瞻性陈述系基于 Atlas Lithium 及其子公司当前计划、估算与预测，且受固有风险与不确定因素影响，实际结果可能与前瞻性陈述有所不同。此类陈述包括但不限于市场及产业细分成长、需求及新旧产品接受度；生产、储量、销售、盈余、收入、利润率或其他财务项目之任何预测；管理层对未来运营之计划、策略及目标；未来经济状况或绩效之任何陈述；在巴西经营业务之不确定性；以及对未来事件之所有假设、期望、预测、意图或信念。因此，投资者不应对该类前瞻性陈述过度依赖。实际结果可能因以下因素（含但不限于）与前瞻性陈述有所差异：Atlas Lithium 成功组装及启动其模块化工厂的能力；Neves 锂项目依最终可行性研究（DFS）报告达成预测产量、开发计划及成本估算；实际与估计矿产储量及资源、实际与估计开发及运营成本、估计与实际产量之差异；持续进行的岩土技术分析结果；巴西之营商环境；整体经济状况、地缘政治事件及法规变更；资金可得性；Atlas Lithium 维持竞争地位之能力；空头操控股价的行为；及对核心管理团队的依赖。公司及其子公司相关其他风险详述于公司于2025年3月28日向美国证券交易委员会（SEC）提交之 Form 10-K“风险因素”章节，以及2025年8月4日提交之 Form 10-Q 中。亦请参阅公司于 SEC 所提交的其他文件，均可于 www.sec.gov 查阅。此外，任何前瞻性陈述仅代表公司当前之观点，且不应视为代表其后续任何日期之观点。公司明确否认有义务更新任何前瞻性陈述。投资人关系Gary Guyton投资人关系副总裁+1 (833) 661-7900gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_Lithium Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月5日 - (亚太商讯 via SeaPRwire.com) - 今日，云顶新耀（HKEX: 1952.HK）宣布旗下中国首个且唯一获得完全批准的IgA肾病对因治疗药物耐赋康®（布地奈德肠溶胶囊）扩产补充申请已正式获得中国国家药品监督管理局（NMPA）批准，标志着该产品在中国市场的供应能力将实现进一步提升。此次扩产获批将进一步提升产能，增加产品供应，更高效地响应中国及亚洲地区对耐赋康®的持续增长的临床需求。为更多IgA肾病患者提供及时、创新的治疗选择。作为全球首个且目前唯一在中国、美国和欧洲获得完全批准的IgA肾病对因治疗药物，自2023年11月在中国获批以来，耐赋康®迅速确立了其作为IgA肾病一线治疗的基石地位，并于2024年11月被纳入国家医保目录。2025年5月，该药品进一步获得NMPA完全批准，适应症不再受限于蛋白尿水平，显著扩大了适用患者群体。据悉，耐赋康®通过特异性调节肠道黏膜免疫，减少诱发IgA肾病的半乳糖缺陷的IgA1（Gd-IgA1）产生，从而阻止下游的病理途径，最终有效控制蛋白尿并保护肾功能。在全球III期NefIgArd研究中，耐赋康®能使肾功能下降风险降低50%，中国人群数据分析显示，能减少66%肾功能下降，疾病进展至透析或肾移植的时间延缓12.8年。云顶新耀首席执行官罗永庆表示：“本次产品生产产能的提高，将更好满足亚洲地区IgA肾病患者日益增长的临床治疗需求。IgA肾病在亚洲高发，其中中国是全球原发性肾小球疾病发病率最高的国家之一，估计目前有超过500万名IgA肾病患者，每年新增确诊患者超过10万例。中国IgA肾病患者的疾病进展快、预后差，临床尚存在巨大未满足的治疗需求。作为目前唯一获国内外指南共同推荐的IgA肾病对因治疗药物，耐赋康®的扩产将加速对因治疗的普及，助力更多患者尽早开启规范治疗、延缓疾病进展、保护肾功能。我们也将持续推动耐赋康®的可及性与可负担性，加速其从‘改变治疗格局’迈向‘重塑治疗标准’。”凭借创新的作用机制和突出的临床优势，耐赋康®先后被纳入《2024版KDIGO IgA肾病和IgA血管炎临床管理实践指南（公开审查版）》以及《中国成人IgA肾病及IgA血管炎临床实践指南（预审版本）》，成为目前唯一同时获国际与国内指南推荐的IgA肾病对因治疗药物。这不仅改变了传统的IgA肾病治疗方案，对因治疗和支持治疗需同时进行，并确立了耐赋康®作为IgA肾病一线治疗的基石地位。目前，耐赋康®已在云顶新耀所有授权区域（包括中国大陆、中国香港、中国澳门、中国台湾、新加坡及韩国）获得批准,在亚洲地区持续拓展其治疗影响力。随着产能的持续扩张和市场供应能力的增强，耐赋康®有望造福更多患者，推动IgA肾病治疗迈入精准治疗新阶段。 Copyright 2025 亚太商讯 via SeaPRwire.com.

NEW YORK, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - Traveler Care, a breakthrough medical dispatch platform that brings urgent care directly to travelers in hotels, Airbnbs, and vacation rentals, has officially launched worldwide - offering travel insurance companies a high-impact solution to reduce avoidable emergency room and hospital claims.Traveler care traveler.care home pageA Concierge Alternative to the Emergency RoomTraveler Care connects travel insurers and their policyholders to a network of licensed, on-call providers who visit travelers in their accommodations - typically within 60-90 minutes. Conditions such as flu, food poisoning, dehydration, allergic reactions, UTIs, sprains, and wound care are treated on-site, eliminating the need for an ER visit."In most cases, travelers just need a doctor - not a hospital admission," said Eli Ofel, founder of Traveler Care. "We've built a scalable, insurer-ready solution that saves money and delivers a far better traveler experience."Reduce Claims by $10,000+ Per VisitOn average, a non-emergency ER visit costs travel insurers $13,000 to $17,000. Traveler Care treats the same conditions in-room for $1,700 to $3,000 - including diagnostics like mobile X-ray, ultrasound, IV therapy, and wound treatment.Pilot results have shown:- 83% reduction in ER claim volume- $10,000+ savings per case avoided- Higher satisfaction scores among travelersBuilt for Travel Insurance PartnersTraveler Care is fully designed for insurance integration - with white-label and API options available for TPAs, underwriters, and global assistance networks.Platform features:- Nationwide U.S. coverage (with international expansion underway)- A robust dispatch network, for example companies like Leaa Health, Sickday, Heal, DocGo and more, any location that the travel insurance is experiencing high volume travel care will create a solution for that particular location within 60 days.- HIPAA-compliant documentation + one-click claims integration- Supports care delivery to hotels, Airbnbs, resorts, and serviced apartmentsNow Onboarding Insurance Companies Worldwide"We believe travel insurance companies shouldn't just pay for care - they should deliver it smarter," said Ofel. "With Traveler Care, you lower claims without compromising care."Insurance providers, TPAs, and global assistance companies are invited to partner and deploy in-room urgent care as part of their medical benefit stack.ContactTo schedule a private demo or receive our ROI case study:Visit www.traveler.careEmail: partners@traveler.carePhone: +1 (347) 733-0563About Eli OfelEli Ofel is a serial entrepreneur and visionary behind multiple AI- and tech-powered platforms in healthcare, finance, and transportation. He is the founder and CEO of Traveler Care, Run.Vet, Leaa Health, 02.Market, and Lender.Market. With over 20 years of experience in healthcare operations, insurance workflows, and mobile logistics, Ofel brings a proven ability to bridge patient needs with scalable platform solutions - saving time, money, and lives.Contact InformationEli OfelCEOeli@traveler.care3477330563SOURCE: Traveler care Copyright 2025 ACN Newswire via SeaPRwire.com.

Boca Raton, Florida--(ACN Newswire via SeaPRwire.com - August 4, 2025) - Atlas Lithium Corporation (NASDAQ: ATLX) ("Atlas Lithium" or "Company"), a leading lithium development company, is pleased to announce that SGS Canada Inc. ("SGS") has completed the Definitive Feasibility Study ("DFS") for the Company's 100%-owned Neves Lithium Project ("Project"), a technical report prepared under the U.S. guidelines of Item 1300 of Regulation S-K ("Regulation S-K 1300"). This hard-rock Project is well-suited to being a low-cost open-pit mining operation, as its spodumene deposits are located relatively close to the surface. Located in the state of Minas Gerais, Brazil, the Project encompasses 4 of the 98 mineral rights for lithium owned by Atlas Lithium. As detailed in the DFS, the Neves Project is expected to deliver strong financial metrics with an internal rate of return ("IRR") of 145%, payback in 11 months from the start of operations, and an after-tax net present value ("NPV") of $539 million. Importantly, the DFS estimates the Neves Project to have operational production costs of only $489 per tonne of lithium concentrate, positioning Atlas Lithium among the world's lowest-cost producers. Complete details of these metrics can be found in the DFS, filed with the Securities and Exchange Commission as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. Marc-Antoine Laporte from SGS serves as the Qualified Person for the DFS under Regulation S-K 1300. SGS is well-known as a global leader in testing, inspection, and certification services for mineral properties and projects.Industry-Leading Capital Efficiency and Low Operating CostsThe DFS supports that expected direct capital expenditures of $57.6 million will be needed for the implementation of the Project, by far the lowest such capital costs among other announced projects in Brazil. Notably, Atlas Lithium has already invested approximately $30 million in acquiring and transporting the Project's newly fabricated dense media separation ("DMS") plant to Brazil, as previously reported. The Company has secured two non-dilutive pre-payment agreements for its lithium concentrate totaling $40 million and has received additional funding interest from other parties, including 10-year debt financing options, any of which could support the Project's capital requirements.The Company believes that the DFS validates the Project's strong economics, positioning it among the most capital-efficient and lowest-cost hard-rock lithium developments globally. The Project will employ proven DMS technology, with comprehensive metallurgical testing demonstrating an expected robust lithium recovery rate of 61.7% to produce high-quality, low-impurity lithium concentrate. This relatively straightforward, low-risk DMS processing methodology minimizes technical complexity and operational risk while enabling a low environmental footprint.Atlas Lithium's mineral right to be mined, as detailed in the DFS, received its "Portaria de Lavra" (mining concession) status from Brazil's Ministry of Mines and Energy on May 27, 2025 — the highest level of titleship in Brazil and one that allows continuous mining operations. Multiple deposit areas within the Project remain open for resource expansion along strike and at depth and are thus expected to extend the life of mine. Additionally, numerous high-potential geological targets remain within the Project's mineral rights, providing compelling opportunities for future exploration.Located in the established Araçuaí Pegmatite District in the Vale do Jequitinhonha, often called Lithium Valley, the Project benefits from favorable infrastructure, including proximity to transportation networks, water resources, and skilled labor. The Project qualifies for tax incentives from the Superintendency for the Development of the Northeast (SUDENE), as promulgated by Brazil's Ministry of Integration and Regional Development, reducing the corporate tax rate from 34% to 15.25% and further enhancing profitability."The DFS indicates potentially outstanding returns for our initial vision of developing a focused, near-term, profitable lithium production asset with minimal capital requirements," said Marc Fogassa, Chairman and CEO of Atlas Lithium. "The combination of our low capital intensity and rapid payback period is expected to create exceptional value for our shareholders while positioning Atlas Lithium to benefit from future organic expansion opportunities at Neves and other high-potential lithium areas that we own. Importantly, we are creating many quality employment opportunities in the Vale do Jequitinhonha region, representing a significant societal contribution of our Project."Experienced Leadership Driving Project ImplementationFollowing his leadership role in collaborating with SGS on the DFS, project implementation activities are being supervised by Eduardo Queiroz, Atlas Lithium's Project Management Officer (PMO) and Vice President of Engineering. Mr. Queiroz has more than two decades of hands-on experience managing complex, large-scale mining projects."The DFS demonstrates the technical robustness of the Project, with proven DMS technology and comprehensive metallurgical test work validated by SGS, a premier firm in the lithium space," said Mr. Queiroz. "With our processing plant fully fabricated and paid for, and now with the DFS in hand, we have systematically de-risked the Project. I am excited to lead the implementation phase of Atlas Lithium's journey to becoming a lithium producer."Salinas and Clear: The Next Expansion FrontierAtlas Lithium is strategically positioned to capitalize on its extensive regional lithium exploration portfolio in Brazil, particularly through advancement of its Salinas Project and Clear Project, both 100% owned by the Company. Atlas Lithium's Salinas Project is just 5 miles east of the Colina lithium asset previously owned by Latin Resources — a major factor in Pilbara Minerals's acquisition of that company in 2024 for approximately $370 million. At the Salinas Project, Atlas Lithium has already achieved promising initial results, including the discovery of spodumene-rich pegmatites very close to the surface, and highly positive results from soil geochemistry and from LIDAR geological mapping.Atlas Lithium's Clear Project is located less than 4 miles from Sigma Lithium's operating lithium mine, and represents significant untapped potential with highly positive results from soil geochemistry and from LIDAR geological mapping.Diversification in Critical MineralsAtlas Lithium also owns approximately 30% of Atlas Critical Minerals Corporation (OTCQB: JUPGF), a separate company with exploration programs in uranium, rare earths, titanium, and graphite.About Atlas Lithium Corporation Atlas Lithium Corporation (NASDAQ: ATLX) is a lithium development company focused on advancing its Neves Project to production. The Neves Project's Definitive Feasibility Study demonstrates excellent economics with a 145% IRR, $539 million NPV, and an 11-month payback. The Neves Project has received operational permitting, and its dense media separation plant has been acquired and transported to Brazil. With approximately 539 square kilometers of lithium mineral rights, Atlas Lithium owns the largest lithium exploration footprint in Brazil among publicly listed companies. Additionally, Atlas Lithium currently holds an approximate 30% ownership stake in Atlas Critical Minerals Corporation (OTCQB: JUPGF).Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based upon the current plans, estimates and projections of Atlas Lithium and its subsidiaries and are subject to inherent risks and uncertainties which could cause actual results to differ from the forward-looking statements. Such statements include, among others, those concerning market and industry segment growth and demand and acceptance of new and existing products; any projections of production, reserves, sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in Brazil, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: Atlas Lithium's ability to successfully assemble and begin operations of its modular plant; reaching estimated production, development plans and cost estimates for the Neves Lithium Project as reported in the Definitive Feasibility Study (the "DFS"); discrepancies between actual and estimated mineral reserves and mineral resources, between actual and estimated development and operating costs, and between estimated and actual production; results from ongoing geotechnical analysis of projects; business conditions in Brazil; general economic conditions, geopolitical events, and regulatory changes; availability of capital; Atlas Lithium's ability to maintain its competitive position; manipulative attempts by short sellers to drive down our stock price; and dependence on key management.Additional risks related to the Company and its subsidiaries are more fully discussed in the section entitled "Risk Factors" in the Company's Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 28, 2025, and in the Company's Form 10-Q filed with the SEC on August 4, 2025. Please also refer to the Company's other filings with the SEC, all of which are available at www.sec.gov. In addition, any forward-looking statements represent the Company's views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.Investor RelationsGary GuytonVice President, Investor Relations+1 (833) 661-7900 gary.guyton@atlas-lithium.comhttps://www.atlas-lithium.com/@Atlas_LithiumTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/261106 Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月4日 - (亚太商讯 via SeaPRwire.com) - 持有花园道三号及朗豪坊物业的冠君产业信托（股份代号：2778），于8月1日成功举办"ESG Gala"压轴活动--青少年电影放映会及职业生涯分享会。本届"ESG Gala"活动以"创新．启发．融合"为主题，透过一系列专题分享、互动体验以及艺术展览，吸引逾千名青年及业界人士参与，展现信托秉持绿色营运与共融理念，推动价值共创，实践多赢局面。信托积极响应香港政府"共创明'Teen'计划"，致力支援来自弱势社群家庭青少年的身心发展，启发他们探索更广阔的未来发展方向。作为本届"ESG Gala"的压轴活动，信托在朗豪坊Gala Cinema包场举办电影放映会，邀请约160名青少年学员及来自18间大型企业的义务友师们，一同欣赏动画电影，现场充满欢乐与感动。放映会后，信托特别邀请本地知名动画师崔氏兄弟与在场青少年分享职涯规划，引领青少年勇于追梦，探索多元发展方向，促进社会向上流动。冠君产业信托行政总裁侯迅女士表示："我们很高兴与一众青少年聚首一堂，希望今天的活动及分享能够启发青少年，勇敢尝试、探索、发掘更多的可能性。未来属于年轻一代，而我们致力成为连接梦想与机遇的平台，与青年同行，共同成长。"本地动画师崔氏兄弟表示："很荣幸能够与青少年分享动画创作及职涯经验。我们相信，只要保持好奇心和坚定信念，勇于尝试，每位年轻人都能找到属于自己的舞台，开创无限未来。"信托连续三年举办ESG主题活动，吸引来自学界、商界、社福界的持份者积极参与与交流，累计参与人次突破50,000，有效加快整个价值链的转型步伐，进一步扩大可持续发展的正面效益。图片说明：冠君产业信托于ESG Gala压轴活动中举办电影放映会，免费邀请约160名共创明"Teen"青少年学员和义务友师一同欣赏动画电影。本地知名动画师崔氏兄弟于放映会后与青少年互动，鼓励年轻人勇敢追梦，探索多元未来。政府共创明"Teen"的学员，包括多元族裔青少年，于朗豪坊参与电影放映会。关于冠君产业信托（股份代号：2778）冠君产业信托拥有及投资提供租金收入的写字楼及零售物业。信托主要投资位于优越地点的甲级商用物业。现时拥有花园道三号及朗豪坊两幢位于香港的地标性物业，并以合资股权形式拥有位于伦敦市中心的66 Shoe Lane，总楼面面积约300 万平方尺，让投资者可直接投资于优质甲级写字楼及零售物业。信托自2023年荣获全球房地产GRESB可持续的最高五星级别。冠君产业信托管理人乃鹰君资产管理（冠君）有限公司，为鹰君集团的成员。网站: www.championreit.com Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Aug 4, 2025 - (ACN Newswire via SeaPRwire.com) - The “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” Technology Forum (the “Forum”), jointly organized by the GBA Economic and Trade Association, GBA Institute, All-China Environment Federation, and “The Hong Kong University of Science and Technology (HKUST) – Absolute Pure EnviroSci Limited (APEL) Joint Laboratory on Health and Environmental Innovation” under APEL, was successfully convened on 29 July 2025 in Hong Kong. The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals to explore forward-looking topics such as solid waste management and advanced materials application, smart manufacturing for industry upgrade, low-carbon building materials, policy coordination across Guangdong-Hong Kong-Macao, and leading-edge advances in smart water quality monitoring and purification. By harnessing technological innovation, the Forum seeks to invigorate the circular economy and inject new momentum into the sustainable development of the Greater Bay Area (GBA).The event was graced by an illustrious roster of speakers and honored guests, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the Hong Kong Special Administrative Region (HKSAR); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group ; Dr. David Chung, Chairman of APEL; Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association; Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation; Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST. These distinguished guests provided strategic and multi-faceted insights into policy, industry, green innovation, and cross-regional collaboration, offering forward-looking recommendations to support the high-quality development of the Greater Bay Area.Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of HKSAR, said, “To drive the low-carbon transition and seize the economic opportunities presented by green development, Hong Kong has established a robust collaborative framework with Mainland cities in the Guangdong-Hong Kong-Macao Greater Bay Area, actively exploring a regional co-operation model for a ‘Zero-Waste City.’ By harnessing their complementary regional strengths, the Mainland and Hong Kong enhance the recovery and recycling of materials in the Greater Bay Area, thereby advancing the circular economy. Through innovation, partnership, and supportive policies, we can transform environmental challenges into new opportunities. I hope today’s discussion will spark innovative ideas and create more opportunities for collaboration, allowing us to work hand in hand toward a greener future.”Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group, highlighted, “The future of technology belongs to courageous pioneers. By uniting the wisdom of ‘Transforming Waste into Value,’ the spirit of ‘Industry Upgrade,’ and the vision of ‘GBA co-creation,’ we will harness the multi-sectoral advantages of investment and infrastructure and make lasting contributions to Hong Kong’s high-quality and sustainable development.”Dr. David Chung, Chairman of APEL, stated, “Technology is the driving force behind economic transformation and higher competitiveness in the new era. By harnessing the power of technology, we seek to ‘Transform Waste into Value’, promote industry upgrades, and accelerate green development. Hong Kong is uniquely positioned—through its entrepreneurial spirit, innovative technologies, robust infrastructure, and global connectivity—to nurture a world-class industrial ecosystem. It is vital that government, industry, academia, research, and investment sectors collaborate closely to advance smart manufacturing, green technology, and high-end manufacturing, while deepening synergies with other cities in the GBA. APEL will continue to align with government policies, foster technological integration and environmental innovation, positioning Hong Kong as a model for new industrialization, driving sustainable development locally and globally.”Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association, emphasized “We believe that technological innovation is the cornerstone for high-quality regional economic growth. Today’s forum marks an important step toward a greener, smarter, and more sustainable future. By applying intelligent solid waste processing and resource regeneration technologies, we can significantly reduce environmental burden of waste and transform it into high-value new materials, extending the value chain for green industries and contributing to national goals of carbon peaking and neutrality.”The Forum gathered nearly a hundred innovation and technology experts, industry leaders, and business professionals, including Miss Diane Wong, JP, Under Secretary for Environment and Ecology Bureau, the Government of the HKSAR (fifth from the right); Mr. Liu Kun, Deputy General Manager, Hunan Construction Investment Group (fourth from the right); Mr. Jackin Jim, Chairman of Yee Hop Holdings Limited (fifth from the left); Dr. David Chung, Chairman of APEL (third from the right); Dr. Pat Yeung, Director of APEL (forth from the left), Dr. Willie Lai, Founder of the GBA Economic and Trade Association (first from the left); Prof. Daniel Cheng, BBS, MH, JP, Honorary President and GBA Honorary Fellow, GBA Economic and Trade Association (third from the left); Mr. Chan Wing Fai, Deputy Director, All-China Environment Federation (second from the right); Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (first from the right); and Prof. Yeung King Lun, Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (second from the left)Fly Ash Recycling Technology Emerges as Key Engine for Circular Economy Development in Greater Bay AreaThe subsequent “Waste-to-Value, Industry Upgrade, and GBA Co-Creation” technology forum brought together experts and industry leaders from various fields for in-depth discussions on three major themes, injecting fresh insights into green technology and regional industrial upgrading. China’s Solid Waste Pollution Prevention and Control Law mandates the safe disposal and resource utilization of fly ash to minimize environmental pollution. Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group, analyzed the advantages and case studies of multi-source solid waste (including fly ash and sludge) treatment and integration with new materials.Dr. Chen Weiguang, Director of the Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences, highlighted that since 2030, China has been progressively reducing landfill disposal of fly ash, encouraging regions with the necessary conditions to achieve zero landfill for incineration residues. Conventional chelation and landfill methods for fly ash—which contains chlorides, heavy metals, and dioxins—are being replaced by innovative two-step processing technology. This approach enables high-value resource recovery, establishing a complete industrial value chain and offering a scalable, replicable solution for near-zero solid waste landfill globally.At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Dr. Chen Weiguang, Director, Digital Low-Carbon Research Institute, Institute of Innovation and Development of Sciences and Technology, Chinese Academy of Sciences (center) and Ms. Huang Jing, Deputy Manager, Overseas Division, Hunan Construction Investment Group (right) engaged in a discussion on waste resource utilization and circular technologies.In the realm of new industrialization and smart manufacturing, Ir. Raymond Shan, General Manager, New Industrialisation Division, Hong Kong Productivity Council (HKPC), and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC shared insights on how automation, digitalization, and AI-driven solutions are advancing upgrade of industries. Ir. Raymond Shan, General Manager of the New Industrialisation Division of HKPC, stated: “Hong Kong is entering a 'New Quality Era'. The HKSAR Government has launched the 'New Industrialisation Funding Scheme (NIFS)' and 'New Industrialisation Acceleration Scheme (NIAS)', which aim to subsidise enterprises engaged in smart and green manufacturing to establish new smart production lines in Hong Kong. HKPC is also cultivating future engineers through a series of future skills training programs, while promoting development in emerging fields such as new energy, bio-health, advanced manufacturing, new materials and artificial intelligence, to consolidate Hong Kong's position as an international innovation hub.”Dr. Alex Choi, Biomedical Specialist of the New Industrialisation Division of HKPC, stated: “In HKPC's initiatives and projects to commercialize R&D achievements in Hong Kong's life & health and new energy industries, we have collaborated with a local enterprise to promote the development of the hydrogen energy sector. The plan includes building Hong Kong's first green hydrogen production facility that will utilize natural biogas from landfills to produce hydrogen. The hydrogen produced at this facility complies with the GB/T 37244-2018 quality standard with purity ≥99.97%, and is suitable not only for transportation use but also for various downstream applications.”At the forum, moderator Dr. David Chung, Chairman of APEL (left), together with Ir. Raymond Shan, General Manager, New Industrialisation Division, HKPC (center) and Dr. Alex Choi, Biomedical Specialist, New Industrialisation Division, HKPC (right) engaged in a discussion on new industrialization and smart manufacturing.On innovative smart water management, Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST, along with Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory, presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies. Mr. Billy Luk said, “Water is an essential resource for sustaining human life and ecological health. Wisepura Aquapura, developed by APEL, utilizes world’s first patented porous silica capsule technology, which intelligently releases active ingredients upon contact with water. This effectively targets over 30 types of over 30 types of bacteria, fungi, and viruses in water supply, air conditioning, and sewage systems while also meeting diverse application needs. Currently, this innovative technology is widely applied across Hong Kong’s public infrastructure. More importantly, the silica capsule can be reused multiple times and safely disposed of at the end of its lifecycle, thereby minimizing environmental impact.”Prof. Han Wei, Research Associate Professor, Department of Chemical and Biological Engineering and Division of Environment and Sustainability, HKUST (left) and Mr. Billy Luk, Chief Application Scientist at the HKUST–APEL Joint Laboratory (right) presented the latest breakthroughs in smart water quality monitoring and efficient purification technologies at the forum.About All-China Environment FederationAll-China Environment Federation (ACEF) is a nationwide non-profitable civil society organization (CSO) in the field of the environment, and is supported by the government. It is composed of CSOs and individuals who are enthusiastic about and support environmental protection and are willing to work for it. The objective of ACEF is to serve as a bridge between the government and the public in implementing the sustainable development strategy, achieving national objectives on environment and development, and protecting the environmental rights of the public. By fully utilizing its organizational advantage, ACEF aims to promote environmental protection and sustainable development in China and the world at large.About GBA Economic and Trade AssociationThe GBA Economic and Trade Association is an economic, trade and financing matching platform initiated and established by business leaders and social elites. Its vision and mission is to cooperate with national policies, assist the economic development of the Greater Bay Area, and provide diversified policy research, analysis and advice, make use of the different advantages and resources of different regions in the region, strengthen economic and trade cooperation, open up four streams: talent flow, goods flow, capital flow and information flow, and accelerate the development of the Bay Area into a world-leading economy.About GBA InstituteThe GBA Institute, founded by the GBA Economic and Trade Association, aims to support the national strategy for the Greater Bay Area's development. Its mission is to cultivate global business leaders and uphold Hong Kong's position as a leading international financial center. The institute partners with prestigious global universities to offer high-level training programs and recognizes outstanding contributors from politics, business, and academia who have made significant contributions to society and the development of the Greater Bay Area.About Absolute Pure EnviroSci LimitedAbsolute Pure EnviroSci Limited (“APEL”), is an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 1662.HK). With a mission to improve the quality of life and living environments, APEL is principally engaged in the research and development and commercialization of health and environmental innovations. Leveraging its Multilevel Antimicrobial Polymer (MAP-1) technology, APEL has developed specialized application formulas in four key areas: air purification in aircraft, water purification, livestock health, and eco-friendly building materials, all designed to address pressing global challenges. On 10 January 2024, APEL jointly established the “HKUST-APEL Joint Laboratory on Health and Environmental Innovation” with the Hong Kong University of Science and Technology (HKUST) to develop and translate novel discoveries into groundbreaking health and environmental innovations. APEL looks forward to working with researchers and industry partners worldwide to drive further health and environmental innovations. To tap into the global health and environmental hygiene market, APEL is currently holding an innovative interactive exhibition at The Lab. in Osaka to showcase its three flagship products—Wisepura water and air purification systems, GERMAGIC™ antimicrobial coating, and GERMAGIC™ PET health care solutions for pets—seizing growth opportunities in Asia’s health technology industry.For inquiries, please contact:AJA (IR & Communications)Avy YuTel: (852) 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年8月4日 - (亚太商讯 via SeaPRwire.com) - 由大湾区经贸协会、大湾区学院、中华环保联合会及Absolute Pure EnviroSci Limited（"APEL"）旗下"香港科技大学-APEL环境科学健康与环境创新联合实验室联合主办的"化废为宝、产业升级、湾区共创"科技论坛于2025年7月29日在香港盛大举行，吸引近百位科创界权威、行业领袖及商界精英共襄盛举，聚焦固废治理与新材料应用、智能制造赋能工业升级、低碳建材创新应用、粤港澳政策协同及智能水质监测与净化科技等前沿议题，以科技创新驱动循环经济，为大湾区可持续发展注入新动能。本次活动特邀多位行业标杆人物发表演讲，包括香港特别行政区政府环境及生态局副局长黄淑娴女士, JP、湖南建投六建集团副总经理刘坤先生、APEL主席钟伟强博士、大湾区经贸协会荣誉会长及大湾区荣誉院士郑文聪教授, BBS, MH, JP、中华环保联合会副主任陈永晖先生，以及香港科技大学化学及生物工程学系、环境及可持续发展学部教授杨经伦教授。多位嘉宾从政策、产业、绿色创新与区域协作等多角度剖析湾区机遇，为大湾区高质发展建言献策。香港特别行政区政府环境及生态局副局长黄淑娴女士表示："为推动低碳转型并及时把握绿色发展带来的经济机遇，香港已与粤港澳大湾区内地城市建立固定的合作机制，积极探索'无废城市'区域共建模式。两地以区域优势互补策略，推动大湾区可回收物料的资源化利用，共同发展循环经济。通过创新、合作和政策引导，我们将能把环保挑战转化为新的机遇。希望今天的讨论能够激发更多的创新思维和合作机会，让我们携手共创绿色未来。"湖南建投六建集团副总经理刘坤先生指出："科技的未来属于敢于突破的实践者，我们能将'化废为宝'的智慧、'产业升级'的魄力、'港区共创'的格局融成一体，充分发挥投资与基建的多领域优势，为香港可持续高质量发展做出贡献。"APEL 主席钟伟强博士表示："科技是推动新时代经济转型和提升竞争力的关键引擎。我们要善用科技力量，实践'化废为宝'，推动产业升级和绿色发展。香港凭藉企业家精神、创新技术、完善基建和国际连系，具备打造世界级产业集群的独特优势。在新时代的发展格局中，官、产、学、研、投五方应紧密合作，推动智能制造、绿色科技和高端制造业，加强与大湾区城市的联动。APEL 将继续配合政府政策，促进科技融合与环保创新，助力香港成为新型工业化的典范，为本地以至全球的可持续发展注入新动力。"大湾区经贸协会荣誉会长及大湾区荣誉院士郑文聪教授表示："我们深信科技创新是推动区域经济高质量发展的核心动力，今天的论坛正是我们迈向绿色、智慧、可持续未来的重要一步。通过智能化的固废处理和资源再生技术，不仅能大幅减少废弃物对环境的压力，还能将其转化为高附加值的新材料，推动绿色产业链的延伸，有效助力国家'碳达峰、碳中和'目标的实现。"本次活动吸引近百位科创界权威、行业领袖及商界精英共襄盛举，出席嘉宾包括香港特别行政区政府环境及生态局副局长黄淑娴女士, JP（右五）、湖南建投六建集团副总经理刘坤先生（右四）、义合控股有限公司主席詹燕群先生（左五）、APEL主席钟伟强博士（右三）、APEL董事杨学光博士（左四）、大湾区经贸协会创办人赖国伟博士（左一）、大湾区经贸协会荣誉会长及大湾区荣誉院士郑文聪教授, BBS, MH, JP（左三）、中华环保联合会副主任陈永晖先生（右二）、中国科学院北京中科科技创新发展研究院数字低碳研究所所长陈伟光博士（右一），以及香港科技大学化学及生物工程学系、环境及可持续发展学部教授杨经伦教授（左二）。飞灰资源化技术势成推动大湾区循环经济发展的关键引擎随后进行的"化废为宝、产业升级、湾区共创"科技论坛，汇聚多位来自不同领域的专家学者与业界代表，围绕三大主题进行深入交流，为绿色科技与湾区产业升级注入崭新洞见。《中华人民共和国固体废物污染环境防治法》等法律法规对飞灰的处置和利用作出了明确规定，要求对飞灰进行无害化、资源化利用，减少对环境的污染。湖南建投六建集团海外公司副经理黄菁女士详细剖析飞灰、污泥等多源固废综合治理与新材料融合的优势及案例。中国科学院北京中科科技创新发展研究院数字低碳研究所所长陈伟光博士指出，2030年起全国逐步减少飞灰填埋量，鼓励实现零填埋。针对飞灰中的氯盐、重金属等污染物，现有整合填埋方式将被创新技术取代，通过二步法工艺实现资源化转型，构建完整产业价值链，为全球固废近零填埋提供可行路径。论坛主持人APEL主席钟伟强博士（左）与中国科学院北京中科科技创新发展研究院数字低碳研究所所长陈伟光博士（中）及湖南建投六建集团海外公司副经理黄菁女士（右）共同探讨废物资源化与循环科技。在新型工业化与智能制造方面，香港生产力促进局新型工业化部总经理单铭贤工程师及生物医学专家顾问蔡永达博士分享了自动化、数字化和AI驱动的工业升级方案。香港生产力促进局新型工业化部总经理单铭贤工程师表示："香港正迈向'新质时代'，特区政府推出的'新型工业化资助计划（NIFS）'和'新型工业加速计划（NIAS）'，旨在资助智能及绿色制造的企业在香港设立新智能生产线。生产力局亦通过提供一系列未来技能培训培育未来工程师，并推动新能源、生物健康、先进制造、新材料及人工智能等新兴领域的发展，巩固香港国际创新中心地位。"香港生产力促进局新型工业化部生物医学专家顾问蔡永达博士表示："生产力局在推动香港生命健康及新能源产业研发成果商业化所进行的措施和项目中，与一家本地企业合作以促进氢能产业的发展，计划兴建香港首座绿色制氢设施，利用堆填区产生的天然沼气制氢。该设施所生产的氢气符合GB/T 37244-2018质量标准，纯度≥99.97%，除了供交通运输使用，亦适用于其他下游应用场景。"论坛主持人APEL主席钟伟强博士（左）与香港生产力促进局新型工业化部总经理单铭贤工程师（中）及香港生产力促进局新型工业化部生物医学专家顾问蔡永达博士（右）共同探讨新型工业化与智能制造议题。关于智能水务创新成果，香港科技大学化学及生物工程学系、环境及可持续发展学部副教授韩伟教授及香港科技大学 (HKUST)-Absolute Pure EnviroSci Limited (APEL) 联合实验室首席应用科学家陆朗霆先生则分享了智能水质监测及高效净化技术的最新突破。陆朗霆先生表示："水资源是维系人类生命与生态环境健康的关键。APEL 研发的 Wisepura Aquapura 采用了全球首创的多孔结构矽微囊专利技术，与水接触时智能控释其活性物质，有效针对供水系统、空调系统及下水道系统中超过 30 种细菌、真菌及病毒，同时满足多种应用场景的需求。目前，这项创新技术已在香港多处公共基础设施广泛应用。更重要的是，矽微囊系统可多次循环使用，且在使用寿命结束后能安全处理，有效减轻环境负担。"香港科技大学化学及生物工程学系、环境及可持续发展学部副教授韩伟教授（左）及香港科技大学 (HKUST)-Absolute Pure EnviroSci Limited (APEL) 联合实验室首席应用科学家陆朗霆先生（右）于论坛上分享了智能水质监测及高效净化技术的最新突破。关于中华环保联合会中华环保联合会是经国务院批准、民政部注册，生态环境部为行业管理部门，由热心环保事业的人士、企业、事业单位自愿结成的、非营利性的、全国性的社团组织。中华环保联合会的宗旨是围绕实施可持续发展战略，围绕实现国家环境与发展的目标，围绕维护公众和社会环境权益，充分体现中华环保联合会"大中华、大环境、大联合"的组织优势，发挥政府与社会之间的桥梁和纽带作用，促进中国环境事业发展，推动全人类环境事业的进步。关于大湾区经贸协会大湾区经贸协会是由社会精英倡导创立的经济贸易及融资配对平台，愿景及使命是配合国家政策，致力推动大湾区的经济发展。积极为各个领域提供商业、经济和融资配对服务，搭建起企业与政府、企业与企业之间的桥梁，促进大湾区成为全球领先的经济体。关于大湾区学院大湾区学院由大湾区经贸协会创办，目的是配合国家的粤港澳大湾区战略规划发展，培育环球企业领袖人才，维持香港作为首屈一指的国际金融中心；并与国际知名高等学府联合举办高端人才培训认证课程"大湾区院士"，与及颁授荣誉名衔予对社会及大湾区建设有杰出贡献的政、商、学界知名人士。关于APELAbsolute Pure EnviroSci Limited（"APEL"）为香港联合交易所主板上市公司--义合控股有限公司（香港主板上市编号：1662）的间接非全资附属公司。以改善生活品质及居住环境为使命， APEL 主要从事健康与环境科技创新的研究、开发及商业化。基于其多层次杀菌涂层技术（MAP-1），APEL 已在四个关键领域：飞机空气净化、水质净化、畜牧健康和环保建材，研发专门的应用配方，旨在应对全球迫切挑战。2024 年 1 月 10 日，APEL与香港科技大学共同建立"香港科技大学-APEL 环境科学健康与环境创新联合实验室"，就创新的健康和环境技术进行研发及成果转化。APEL 期待与全球研究人员和行业伙伴合作，推动更多健康与环境科技创新。为布局国际健康与环境卫生的市场，APEL 现正于大坂 The Lab.举行创新互动展览会，展示三大旗舰产品--Wisepura 水质及空气净化系统、GERMAGICTM 抗菌涂层和 GERMAGICTM PET 宠物健康及护理方案，把握亚洲健康科技产业的发展机遇。如有垂询，请联络：AJA (IR & Communications)庾婉华电话：(852) 9500 4443电邮：avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.

SINGAPORE, Aug 3, 2025 - (ACN Newswire via SeaPRwire.com) - GK8, Asia's leading platform for interactive gaming and entertainment, has proudly announced football legend Michael Owen as its newest brand ambassador. With a reputation built on trust, security, and a diverse range of gaming options, GK8 continues to expand its influence in the iGaming sector, and Owen's partnership is set to bolster its position in the competitive industry. Related link: https://youtu.be/9rTOPTyOcP0A Stellar Partnership for GK8Michael Owen, a former English football star known for his exceptional skills and quick pace on the field, brings his star power to the fast-growing brand. With years of success both on and off the pitch, Owen's influence will help enhance GK8's visibility across key international markets. The partnership marks a pivotal moment for the company, reflecting its ambition to continue expanding globally while maintaining its commitment to a high standard of user experience."It's an honor to be working with such a dynamic and forward-thinking brand like GK8. Their dedication to creating a secure, engaging platform aligns perfectly with my values," said Michael Owen. "I look forward to connecting with fans and players in Southeast Asia, sharing in the excitement and entertainment that GK8 offers."The Rise of GK8Founded with a vision to bring top-tier gaming experiences to Asia, GK8 has rapidly grown into a major force in the interactive gaming industry. The platform is recognized for its advanced security measures, seamless user interface, and wide selection of games, including sports, lotteries, and multiplayer online options. GK8's unique approach to customer service has helped them build a loyal global community, with users praising its responsive support team and fast transactions.Asia's largest iGaming platform, GK8 is now expanding its reach into markets beyond the region, including Malaysia, Thailand, and Indonesia. As the platform continues to grow, the inclusion of Michael Owen as its new ambassador will undoubtedly help the brand strengthen its position in key global markets, particularly in the UK and Europe, where Owen is a household name.A Secure and Trusted PlatformWhat sets GK8 apart is its unwavering focus on security and user privacy. The platform operates under stringent regulations, ensuring that every user's data and personal information is handled with the utmost confidentiality. GK8's commitment to offering a safe, encrypted environment for its users is reflected in its partnerships with renowned testing laboratories like BMM Testlabs and iTech Labs.In addition to high-security standards, GK8 ensures that its players have access to the latest, most innovative gaming experiences. The platform is constantly updating its offerings, liaising with international vendors to introduce exciting new games regularly."We are extremely proud of the trust our customers place in us," said a spokesperson from GK8. "With Michael Owen on board, we're excited to continue delivering world-class service and cutting-edge gaming options, ensuring a secure and enjoyable experience for our global community."Supporting Responsible EntertainmentWhile GK8 continues to grow its offerings, the platform remains committed to promoting responsible entertainment. The company's comprehensive support services, 24/7 live chat assistance, and responsible gaming policies ensure that users can engage in a safe and enjoyable environment. Whether new to the platform or a seasoned player, GK8 strives to deliver a rewarding experience while adhering to ethical standards."GK8's priority has always been our users' satisfaction and well-being," the spokesperson continued. "With a strong emphasis on security, customer service, and an ever-evolving gaming selection, we are proud to be the go-to platform for millions of players worldwide."Expanding Global PresenceCurrently available in several Asian markets, GK8 plans to broaden its global reach in the coming years. As it continues to push the boundaries of innovation and security, the brand is set to make a significant impact in new regions.With Michael Owen now acting as the face of GK8, the company is ready to elevate its brand to the next level. This partnership highlights GK8's growth, global ambitions, and commitment to providing the best possible entertainment experience for all of its users.As one of the fastest-growing brands in the interactive gaming sector, GK8 remains steadfast in its mission to lead the way with security, innovation, and world-class service. The collaboration with Michael Owen marks the beginning of a new chapter for the platform, setting the stage for even greater success in the years to come.About GK8GK8 is owned and operated by GK8 Ltd. registration number: 000047418, registered address: BZAGENTS Limited, Sea Urchin Street, San Pedro,Ambergris Caye, Belize. Contact us support@gk8.com. GK8 is licensed and regulated by the Government of the Autonomous Island of Anjouan, Union of Comoros and operates under License No. ALSI-202505017-FI1. GK8 has passed all regulatory compliance and is legally authorized to conduct gaming operations for any and all games of chance and wagering.For more information about GK8 and the latest gaming offerings, visit www.gk8.com.Media ContactBrand: GK8Contact: Media TeamWebsite: https://www.gk8sentosa.com Copyright 2025 ACN Newswire via SeaPRwire.com.

TORONTO, ON, Aug 2, 2025 - (ACN Newswire via SeaPRwire.com) - Kuvi.ai, the platform pioneering Agentic Finance, has announced the successful completion of its $700,000 seed round, led by Moon Pursuit Capital, and the expansion of its strategic round, which is now oversubscribed. Recent additions include legendary crypto investor Michael Terpin of Transform Ventures and leading Web3 educator Dennis Liu (aka VirtualBacon).The announcement follows Kuvi.ai's earlier pre-seed (angel) round, which closed in just four days. With the close of the seed round and the opening of the strategic round, Kuvi.ai's valuation has now doubled from $15 million to $30 million.The funding supports the private beta launch of Kuvi.ai's Agentic Finance Operating System (AF-OS), the first of its kind next-gen interface that empowers users to design, automate, and deploy complex financial strategies using natural language.Kuvi.ai replaces the need for centralized exchanges, clunky DeFi dashboards, or opaque robo-advisors, enabling users to act with precision, automation, and control. Kuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces.Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest. Unlike pre-programmed bots or chat wrappers, Kuvi.ai allows users to define their financial intent - e.g., "Buy $1K in memecoins when sentiment spikes and gas is low, exit when BTC dominance rises" - and executes via our proprietary modular and functional agentic framework."Kuvi.ai is building the coordination layer for agentic value transfer," said co-founder and CEO Dylan Dewdney.Kuv.ai's private beta, rolling out now to early community, investors, supporters, collaborators, and some OTC desks, introduces smart "Executables." These are automations tied to market conditions, cross-chain actions, and real-time data. Early integrations include top Solana-native protocols like Raydium and Jupiter, with Ethereum and Bitcoin native protocols soon to follow."This is not just a new product," added co-founder and CTO Jay Nasr. "It's a complete rethink of how humans interact with financial systems."With private beta underway and TGE tentatively slated for late summer/early fall 2025, Kuvi.ai is set to scale its user base, integrations, and community. As the Agentic Finance movement gains traction, Kuvi.ai is positioned to be the flagship OS in a post-app financial world - empowering everyone to manage and multiply wealth through intent-based interfaces.About Kuvi.aiKuvi.ai is an AI-driven crypto interface designed to make digital asset transactions as simple as typing a message or saying a few words, delivering text-to-trade functionality that removes the need to navigate multiple dApps, bridging solutions, or complex trading interfaces. Users can instruct Kuvi.ai to buy, sell, or swap tokens across blockchains, and Kuvi.ai does the rest.Kuvi.ai is founded by Dylan Dewdney, a crypto OG active since 2011, along with Jay Nasr, and Maxim Sindall, bringing technical depth and go-to-market execution. Kuvi.ai's momentum is powered by a heavyweight advisory and investor roster that includes Michael Terpin, founder of Transform Ventures and early advisor/investor to hundreds of crypto projects, including Ethereum and Tether; Dennis Liu (VirtualBacon), top-tier crypto educator with 400K+ followers; and Peter Vincer, advisor with institutional and U.S. policy access, joins as Advisor for Government Relations. For more information, please visit https://kuvi.ai .Social LinksX: @kuvilabsTelegram: @kuviai Discord: https://discord.com/invite/r5Hfpk5BPaMedia contactBrand: Kuvi.aiContact: Media teamWebsite: https://kuvi.ai Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 2, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash. Upon completion of the subscription and inclusive of shares already held, Everest will own approximately 16.1% of I-Mab’s total outstanding shares.Under the terms of the agreement of this offering, Everest will subscribe for 15,846,154 newly issued American depositary shares (ADSs) of I-Mab at a price of US$1.95 per ADS, for a total consideration of US$30.9 million. Upon completion, Everest will hold a total of 15,846,154 ADSs and 6,078,571 ordinary shares, representing approximately 16.1% of I-Mab’s total issued share capital, inclusive of 6,078,571 ordinary shares it already owns. In addition to Everest, several leading global institutional investors are participating in this offering, including Janus Henderson Investors, Adage Capital Partners LP, Woodline Partners, and Exome Asset Management.This strategic investment marks a significant step in Everest’s ongoing efforts to strengthen its position in next-generation cancer immunotherapy. It also reflects the strong clinical and business development complementarity and synergy between the two companies. I-Mab’s Claudin 18.2 x 4-1BB bispecific antibody, givastomig, demonstrated an impressive overall response rate (ORR) of 83% in combination with immunotherapy in a Phase 1b trial for first-line gastric cancer. I-Mab’s differentiated 4-1BB receptor-targeting platform and bispecific antibody pipeline are highly complementary with Everest’s existing mRNA cancer vaccine and in vivo CAR-T platforms.In addition, I-Mab’s unique clinical translational capabilities, particularly in the U.S., combined with Everest’s clinical capabilities in Asia, could help accelerate the development and global expansion of pipeline products for both companies.“This strategic equity investment furthers our plan to be an active player in next-generation oncology programs across global markets. Everest and its Board of Directors believe this investment recognizes I-Mab’s unique clinical translational capabilities in the U.S., which are complementary and synergistic with the Company’s strong Asia presence,” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “As a biotech pioneer in China, Everest has built internally developed pipeline assets including mRNA therapeutic cancer vaccines and in vivo CAR-T therapies targeting cancer and autoimmune diseases. Our areas of focus meaningfully intersect with I-Mab’s differentiated 4-1BB platform and bispecific antibody pipeline, including oncology candidates Givastomig (Claudin 18.2 x 4-1BB bispecific antibody) and Ragistomig (PD-L1 x 4-1BB bispecific antibody), both promising programs that we are closely watching. Furthermore, both companies may be able to leverage their combined expertise to run clinical programs in both China and the U.S. Everest is proud to develop innovative and valuable therapies that can benefit cancer patients globally.”The strategic equity investment not only strengthens Everest Medicines’ position in next-generation immuno-oncology, but also extends the global development path of its proprietary AI-powered mRNA platform. As a key pillar of Everest’s “dual-engine” strategy of in-licensing and internal innovation, the company has made solid progress in building and internationalizing its AI+mRNA platform. Multiple pipeline programs are advancing in preclinical research, with a strong focus on oncology and autoimmune diseases. Looking ahead, Everest will accelerate global clinical development and regulatory efforts, while actively exploring collaborations with leading international biopharmaceutical companies to maximize the value of its platform and bring breakthrough therapies to patients worldwide. Copyright 2025 ACN Newswire via SeaPRwire.com.

MERAUKE, Indonesia, Aug 1, 2025 - (ACN Newswire via SeaPRwire.com) - Berkat Cipta Abadi (BCA), a subsidiary of oil palm plantation and processing giant Tunas Sawa Erma (TSE) Group, launched a biogas and compressed biomethane gas plant in Papua. The plant will help TSE Group manage their production waste better and create a practical energy solution, while marking an important milestone in the company’s journey toward its vision and net-zero emissions.The South Papuan Governor (fourth from right), Merauke Regent, and Tunas Sawa Erma (TSE) Group CEO with state officials and company executives after a plaque signing marking the launch of TSE's renewable energy plant in Merauke Regency, South Papua (Aug 1, 2025)"What we're launching today is the product of our vision at TSE Group. We're aiming to build an efficient, advanced industry that's also sustainable, environmentally safe, and community-orientated,” said TSE Group's CEO Robert Seung in his opening speech.The biogas and compressed biomethane gas (CBG) plant will convert 1,000 m³ of palm oil mill effluent (POME) into methane on a daily basis, with most of the output providing environmentally friendly electricity for BCA's factories and administrative buildings.The remaining gas will be compressed and used to fuel electricity generators in some parts of the operational site. This way, diesel consumption can be further reduced by 1 million litres per year, ensuring greater energy efficiency across TSE Group offices.TSE Group CEO Robert Seung leads Merauke Regent Yoseph B. Gebze (R) and South Papuan Governor Apolo Safanpo (L) on a demonstration tour of the new biogas and compressed biomethane gas (CBG) plants on Friday (Aug 1, 2025).BCA expects to benefit from annual cuts in emissions reaching 60,708 tonnes, a power supply of 2 megawatts for its 150-tonnes-per-day palm kernel crushing plant, and an annual diesel reduction of 4 million litres.Friday's launch also opened a new chapter in POME-based energy adoption and public-private collaboration supporting Indonesia's carbon-slashing NDC commitment. This commitment also aligns with the Paris Agreement's target to limit global warming to 2°C.The first of its kind in the region, the facility was inaugurated in a ceremony entitled "Green Power, Born from Waste: Papua's First Biogas Power Launch," attended by South Papuan Governor Apolo Safanpo, Merauke Regent Yoseph B. Gebze, South Papuan People's Assembly Chairman Damianus Katayu, Merauke Regional People’s Representative Council members, Merauke Departmental Police Force leader Leonardo Yoga, and other local state officials.TSE Group CEO Robert Seung explains Papua's first POME-to-energy plant to visitors on hand for the plant's inauguration on Friday (Aug 1, 2025)South Papua Governor Apolo Safanpo showed his support, saying the biogas plant aligns with state plans to achieve food and energy independence. "It's a good start to food and energy independence. Thank you, TSE Group, for initiating biogas development in Papua. I hope this site sets an example for regions outside Merauke Regency."Similar praises were echoed by Merauke Regent Yoseph B. Gebze. "On behalf of the Merauke government and people, we want to congratulate TSE Group for the launch. We hope this renewable energy facility propels a region-wide shift towards eco-friendly developments."Biogas facilities will be built in five other locations belonging to TSE Group subsidiaries. In the meantime, the corporation will expand its green initiatives, e.g., EV, solar energy, and eco-friendly fertiliser use in its operations. TSE Group believes its efforts would encourage more palm oil players to achieve end-to-end sustainability and bring a better future for all.For more information, please visit https://www.tsegroup.co.id or contact the TSE Group at pr@tsegroup.co.id. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 1, 2025 - (ACN Newswire via SeaPRwire.com) - Concord New Energy Group (“CNE” or "the Group", Stock Code: 0182.HK), announced its interim results for the six months ended 30 June, 2025 (the "Period"). In the first half of 2025, the Group's newly built power plants were successively commissioned, and financing costs were further reduced. However, facing the dual challenges of worsening curtailment in certain regions of China and a decline in comprehensive electricity prices, the Group's core business came under pressure, resulting in a decrease in both revenue and profit. In response, the Group promptly adjusted its development strategy in light of the changing environment. With the goal of enhancing profit certainty, we adjusted our business strategies to prioritize quality. Guided by the principles of improving efficiency and creating value, the Group focused on enhancing the profitability of its power plants, strengthening its power trading capabilities.During the period, the Group achieved the continuing operations revenue of RMB1.4 billion, representing a year-on-year drop of 6.6%. Profit attributable to equity holders of the Group amounted to RMB282 million, with a net profit margin of 20%. Basic earnings per share was RMB3.58 cents. As of 30 June 2025, the Group had net assets of RMB8.9 billion and net assets attributable to equity shareholders of the Group per share was RMB1.11.In the first half of 2025, the Group continued to expand the presence in key international markets and strengthened project development capabilities. The Group secured 600 MW of new wind investment projects (listed in annual construction plans) in China, and 152.5 MW of solar projects and 300 MW of energy storage projects outside China. Additionally, during the development of power plant projects, the Group created multi-dimensional synergies with its professional service businesses, including power plant O&M, design, consulting and power trading. The contract value of newly signed external agreements for power plant O&M, design and consulting grew significantly.During the period, the Group successfully achieved the on-schedule grid connection of multiple projects through meticulous planning and organization. In the first half of 2025, the Group's newly commissioned projects added an attributable capacity of 191 MW, including 140 MW of wind and 51 MW of solar power. As of 30 June 2025, the Group owned operational wind and solar power plants with an attributable installed capacity of 4,778 MW, representing a year-on-year increase of 18.0%. This includes 3,844 MW from wind farms, an improvement of 10.9% year-on-year, and 934 MW from solar PV power plants with a year-on-year growth of 60.0%. The attributable installed capacity of the Group’s subsidy-free power plants has reached 3,380 MW, accounting for 70.7% of the Group’s total attributable installed capacity.In the first half of 2025, affected by adverse factors such as unfavorable wind resources, increased curtailment at some power plants and a decrease in the comprehensive electricity price, the Group's power generation revenue declined by 2.1%, accompanied by a decrease in net profit from power generation. During the period, the Group's attributable power generation remained stable compared to the same period last year, reaching 4,759GWh. The Group's weighted average utilization hours for wind farms were 1,142 hours, and for solar PV power plants, they were 531 hours. Additionally, the Group strengthened green electricity trading and green certificate sales, with green electricity transaction volume increasing by 26% year-on-year, effectively offsetting the adverse impact of the overall decline in electricity prices.Meanwhile, the Group concentrated on refined and professional management, reduced financing costs continuously and improved the efficiency of power plants. During the period, the average financing cost for newly drawn loans decreased to 3.15%, and the Group's overall financing cost fell to 3.63%, both remaining at low levels. The Group reduced power generation losses caused by equipment failure by 40%.Mr. Liu Shun Xing, Chairman of the Board of Directors of Concord New Energy Company Limited indicates, “In response to the rapidly evolving landscape of the new energy sector, the Group has implement a series of operational adjustments. Guided by the principles of enhancing efficiency and creating value, we have optimized our business strategies. At the same time, we strengthened management through a focus on ‘refinement and specialization.’ These efforts have yielded meaningful cost reductions and efficiency gains. We have also made concerted efforts to strengthen our power trading capabilities, with a strong focus on electricity marketing, expanding green power transactions and green certificate sales, and actively developing our global business. These initiatives have begun to show promising results. Looking ahead, the Group has formulated and is executing a new development strategy, underpinned by the objective of ‘strengthening the enterprise and enhancing the certainty of profitability.’ We will place greater emphasis on the quality of growth, with the aim of delivering greater returns to our shareholders.” Copyright 2025 ACN Newswire via SeaPRwire.com.